Morenzo Abadi Perkasa Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Morenzo Abadi Perkasa Tbk. trades at Rp68 (market cap 149.22B, 569K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 23.2K 24h volume). The key difference: Morenzo Abadi Perkasa Tbk. and Brigit Biofarmaka Teknologi Tbk. are close in size by market cap, and Morenzo Abadi Perkasa Tbk. is more actively traded (569K versus 23.2K). Which is the better fit depends on your goals.
| ENZO | OBAT | |
|---|---|---|
Market Cap | 149.22B | 167.37B |
Volume | 569K | 23.2K |
Lot | 5.69K | 232 |
Turnover | 38.8M | 5.73M |
Average Price | 68.19 | 246.93 |
Value | 38.8M | 5.73M |
Indicative Equilibrium Price | 69 | 246 |
Indicative Equilibrium Volume | 66K | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Morenzo Abadi Perkasa Tbk, (The “Company”) was established based on Notarial Deed No. 21 of Jhon Langsung, S.H., dated January 10, 2013. Company commenced its commercial business activities in 2013. PT Tritunggal Sukses Investama is the ultimate Parent Entity and Parent Entity of the Company and Mr. Markus Silitonga as the ultimate shareholder.
Read more on ENZO →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →